Eye scan study to test a new imaging method in healthy adults
Part of Eyes & vision clinical trials.
This study checks whether a specific eye-scanning technology gives consistent, repeatable results. It enrolls healthy adults to see if the test works reliably before being used more broadly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 35 years old
- Do not smoke
- Have normal eye findings and only mild vision prescription (less than 3 diopters)
- No regular medicines, and avoid most new drugs for the 3 weeks before the first visit (birth control is allowed)
- Be able to confirm you are not pregnant, not planning pregnancy, and not breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares eye blood-flow/brain-eye communication signals in people with glaucoma (or high eye pressure) versus people with normal eye tests. It may help researchers understand how glaucoma develops and progresses.
This study measures blood flow and oxygen use in the retina (the light-sensing layer at the back of your eye) in adults with type 2 diabetes and in healthy adults. It may help researchers better understand how diabetes affects the eye.
This study measures how blood flow in the eye changes in people with relapsing-remitting multiple sclerosis (RRMS) who previously had optic neuritis. The goal is to understand eye/brain blood-flow signals and how they may relate to MS.
This study uses a special eye scan (OCT) to measure the tear film in healthy adults and in people with dry eye. It may help researchers understand what’s different in dry eye and how well the scan reflects dry eye symptoms.
This study uses a detailed eye scan (optical coherence tomography angiography) to look at how blood vessels in the retina are affected. It may help researchers better understand retinal vascular diseases, though some people will be excluded for safety or image-quality reasons.
This study uses a new laser technology (HoloDoppler) to measure blood flow in the eye. It aims to understand how blood flow is affected in people with glaucoma, carotid artery narrowing, or certain choroidal diseases, compared to healthy volunteers.
Hear when a new Ocular Blood Flow trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.